No.96 Apr.9th-Apr.29th

Total Investment of 2 Billion Yuan: Asymchem's New Project Lands in TEDA

TEDA signed a memorandum of cooperation with Asymchem Group, marking the official landing of Chemical Macromolecule Innovative Drug CDMO R&D and Production Integration Project in TEDA. With a total investment of 2 billion yuan, the project will focus on areas such as oligonucleotides, peptides, and high-end pharmaceutical new materials, further enhancing Asymchem's one-stop CDMO service capabilities and helping TEDA improve its biomedical industry chain.

German Niche Industry Leader LIFTKET Group Opens Its First Chinese Factory in TEDA

Liftket Technology (Tianjin) Co., Ltd. officially opened in TEDA. As the first production subsidiary in China of Germany's LIFTKET Group, a global leader in electric chain hoist manufacturing, Liftket Technology Tianjin will fully introduce European advanced manufacturing standards, intelligent automation control technology, and lean management concepts. Focusing on three areas like industry, wind power, and stage entertainment, it will launch high-tech threshold stage hoist products tailored to local needs and vigorously promote localized procurement of the supply chain.

HBP Energy Equipment Production Base Commences Operation

The HBP Energy Equipment Production Base officially commenced operation in the West Zone of TEDA. The project, built by China Oil HBP Group, a leading listed company in China's oil and gas development and utilization field, has a total investment of no less than 500 million yuan. It focuses on introducing advanced automated production lines and digital management systems, effectively strengthening the region's technological foundation in heavy and precision manufacturing.

Qingtai Beijing-Tianjin-Hebei Collaborative Innovation Base Project Breaks Ground

The Qingtai Beijing-Tianjin-Hebei Collaborative Innovation Base project started construction in TEDA. With a total investment of approximately 500 million yuan, the base relies on multiple technology transfer projects from Tsinghua University, focusing on three directions: micro-nano manufacturing, biomedical machinery, and high-end equipment. It aims to create a distinctive park integrating industrial incubation and high-end manufacturing.

FAW-Volkswagen Tianjin Branch's New Hybrid Model Rolls off the Line in TEDA

The first vehicle of the all-new Tayron L PHEV officially rolled off the production line at FAW-Volkswagen Automotive Co., Ltd. Tianjin Branch. This milestone marks the company's successful achievement of flexible co-production of fuel-powered and plug-in hybrid electric vehicle (PHEV) models, represents a key step in its new energy transformation. It will inject strong momentum into the high-quality development of TEDA's automotive industry.Positioned as a mid-to-high-end plug-in hybrid SUV for the household market, the all-new Tayron L PHEV offers a comprehensive driving range exceeding 1,200 kilometers and is equipped with an advanced intelligent driving assistance system, significantly enhancing travel safety and convenience.

Great Wall Motor's New Model Produced in Tianjin Rolls Off Assembly Line and Begins Global Pre-Sales

Great Wall Motor invested 3.2 billion yuan in Tianjin to deploy a new-generation full-power intelligent super platform—One. The first model built on this platform, the Wey V9X, officially began global pre-sales, and the new model simultaneously rolled off the assembly line at Great Wall Motor's Tianjin production base in TEDA. As the first full-power intelligent super platform in China, the One platform can break down components such as the engine, battery, and chassis into 329 standard modules, enabling modular production according to different order requirements, achieving rapid production switching between different models, and further reducing the lead time.

Made in TEDA! China's First Three-Component DTaP Vaccine Approved for Market

CanSino Biologics' self-developed adsorbed acellular pertussis (three-component), diphtheria, and tetanus combined vaccine for infants, Pankangxin®, received approval from the National Medical Products Administration, becoming the first such vaccine approved in China. Pankangxin® contains three key antigens—PT, FHA, and PRN—offering more comprehensive protection with pure components, and reduces the incidence of fever reactions by more than 50% after booster immunization.

31 Achievements from TEDA Win 2025 Tianjin Science and Technology Awards

The official list of winners of the 2025 Tianjin Science and Technology Awards was announced, with 31 achievements from TEDA receiving awards. Among them, there was one Special Prize and one First Prize for Technological Invention, seven First Prizes and 19 Second Prizes for Science and Technology Progress. The award-winning achievements cover key industrial tracks such as information technology innovation, high-end equipment, biomedicine, new energy, new materials, and artificial intelligence, deeply aligning with the region's "4+2+X" future industrial development system, fully demonstrating TEDA's hardcore strength in the field of technological innovation.

Human Resources Global Expansion Service Event Held in TEDA

The Human Resources Global Expansion Service Event was held at the China Tianjin Human Resources Service Industrial Park (Binhai Industrial Park). As one of the core components of the 2026 China Human Resources Service Industry Development Strategy Conference and Beijing-Tianjin-Hebei Talent Cooperation and Exchange Event, the event attracted over 200 guests from human resources and social security departments, human resources industrial parks, human resources enterprises, and service institutions across the country, jointly exploring development paths to empower talent institutions and safeguard enterprises going global.